Interneuron test-marketing Melzone low-dose melatonin sleep aid in Boston in July.
INTERNEURON TEST MARKET OF MELZONE LOW-DOSE MELATONIN SLEEP AID begins in July in the Boston area. According to the company, Melzone contains "the dose believed to be appropriate to raise blood melatonin levels to normal nighttime levels, following which, these levels fall again each morning, consistent with a normal day-night rhythm in blood melatonin levels." Interneuron Pharmaceuticals said that it plans "limited" advertising for the product.